Sinovac Biotech SHS
(SVA)
|
42.5 |
$615M |
|
5.9M |
104.30 |
Harmony Biosciences Holdings Common
(HRMY)
|
6.3 |
$92M |
|
2.6M |
35.19 |
Verona Pharma Ads
(VRNA)
|
6.2 |
$90M |
|
4.2M |
21.14 |
Avadel Pharmaceuticals Adr
|
4.4 |
$63M |
|
3.8M |
16.48 |
Terns Pharmaceuticals Common
(TERN)
|
4.0 |
$58M |
|
6.7M |
8.75 |
Geron Corp Common
(GERN)
|
3.7 |
$53M |
|
17M |
3.21 |
Tarsus Pharmaceuticals Common
(TARS)
|
2.8 |
$41M |
|
2.3M |
18.07 |
Viridian Therapeutics Common
(VRDN)
|
2.8 |
$40M |
|
1.7M |
23.79 |
VectivBio Holding Common
|
2.7 |
$39M |
|
2.3M |
16.87 |
Chinook Therapeutics Common
|
2.5 |
$36M |
|
935k |
38.42 |
ALX Oncology Holdings Common
(ALXO)
|
2.2 |
$32M |
|
4.2M |
7.51 |
Cogent Biosciences Common
(COGT)
|
1.8 |
$27M |
|
2.2M |
11.84 |
Icosavax Common
|
1.2 |
$17M |
|
1.7M |
9.93 |
Gracell Biotechnologies Sponsored Ads
|
1.0 |
$15M |
|
4.0M |
3.81 |
Astria Therapeutics Common
(ATXS)
|
1.0 |
$14M |
|
1.7M |
8.33 |
Ventyx Biosciences Common
(VTYX)
|
1.0 |
$14M |
|
422k |
32.80 |
Arcellx Common
(ACLX)
|
0.9 |
$14M |
|
434k |
31.62 |
Allakos Common
(ALLK)
|
0.9 |
$13M |
|
3.0M |
4.36 |
Zai Lab Adr
(ZLAB)
|
0.9 |
$12M |
|
446k |
27.73 |
Olema Pharmaceuticals Common
(OLMA)
|
0.8 |
$12M |
|
1.3M |
9.03 |
Verastem Common
(VSTM)
|
0.8 |
$11M |
|
1.5M |
7.44 |
Compass Therapeutics Common
(CMPX)
|
0.8 |
$11M |
|
3.6M |
3.18 |
Aslan Pharmaceuticals Ads
|
0.7 |
$10M |
|
2.8M |
3.65 |
Alpine Immune Sciences Common
|
0.6 |
$9.4M |
|
915k |
10.28 |
Aclaris Therapeutics Common
(ACRS)
|
0.6 |
$9.3M |
|
899k |
10.37 |
Amyris Common
|
0.6 |
$8.0M |
|
7.8M |
1.03 |
KalVista Pharmaceuticals Common
(KALV)
|
0.5 |
$7.7M |
|
856k |
9.00 |
Genetron Holdings Ads
|
0.5 |
$7.6M |
|
8.1M |
0.93 |
Instil Bio Common
|
0.5 |
$6.9M |
|
13M |
0.55 |
Delcath Systems Common
(DCTH)
|
0.5 |
$6.9M |
|
1.2M |
5.83 |
Dyne Therapeutics Common
(DYN)
|
0.4 |
$6.5M |
|
578k |
11.25 |
Aadi Bioscience Common
(AADI)
|
0.4 |
$6.5M |
|
510k |
12.67 |
Sera Prognostics Common
(SERA)
|
0.4 |
$6.1M |
|
1.9M |
3.29 |
IO Biotech Common
(IOBT)
|
0.4 |
$5.9M |
|
3.0M |
1.96 |
DBV Technologies SA Sponsored ADR
|
0.4 |
$5.1M |
|
2.7M |
1.90 |
Bolt Therapeutics Common
(BOLT)
|
0.3 |
$5.0M |
|
3.9M |
1.28 |
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.3 |
$4.9M |
|
137k |
35.66 |
Iovance Biotherapeutics Common
(IOVA)
|
0.3 |
$4.6M |
|
655k |
7.04 |
Clene Common
(CLNN)
|
0.3 |
$3.7M |
|
4.5M |
0.82 |
Impel NeuroPharma Common
|
0.3 |
$3.7M |
|
2.9M |
1.27 |
Aligos Therapeutics Common
(ALGS)
|
0.2 |
$3.4M |
|
3.5M |
0.97 |
BioAtla Common
(BCAB)
|
0.1 |
$1.9M |
|
637k |
3.00 |
Fulcrum Therapeutics Common
(FULC)
|
0.1 |
$1.8M |
|
550k |
3.30 |
Immunic Common
(IMUX)
|
0.1 |
$1.6M |
|
632k |
2.51 |
Codexis Common
(CDXS)
|
0.1 |
$1.1M |
|
388k |
2.80 |
Rezolute Common
(RZLT)
|
0.1 |
$969k |
|
490k |
1.98 |
Homology Medicines Common
|
0.0 |
$328k |
|
370k |
0.89 |
Precision Biosciences Common
|
0.0 |
$74k |
|
140k |
0.53 |